{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T14:33:55Z","timestamp":1780497235295,"version":"3.54.1"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T00:00:00Z","timestamp":1754092800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.rmed.2025.108292","type":"journal-article","created":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T22:11:58Z","timestamp":1754431918000},"page":"108292","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Comparing major COPD triple therapy trials using a structured multi-criteria decision analysis: A deep dive into patient populations and outcomes"],"prefix":"10.1016","volume":"247","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4895-9707","authenticated-orcid":false,"given":"Mario","family":"Cazzola","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6751-9921","authenticated-orcid":false,"given":"Mauro","family":"Maniscalco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Patella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigino","family":"Calzetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Gabriella","family":"Matera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7801-5040","authenticated-orcid":false,"given":"Paola","family":"Rogliani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.rmed.2025.108292_bib2","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1164\/rccm.202108-1819PP","article-title":"An updated definition and severity classification of chronic obstructive pulmonary disease exacerbations: the rome proposal","volume":"204","author":"Celli","year":"2021","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.rmed.2025.108292_bib3","doi-asserted-by":"crossref","first-page":"165","DOI":"10.2147\/COPD.S345263","article-title":"Beyond dual bronchodilation - triple therapy, when and why","volume":"17","author":"Cazzola","year":"2022","journal-title":"Int. J. Chronic Obstr. Pulm. Dis."},{"issue":"18","key":"10.1016\/j.rmed.2025.108292_bib4","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1056\/NEJMoa1713901","article-title":"Once-daily single-inhaler triple versus dual therapy in patients with COPD","volume":"378","author":"Lipson","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.rmed.2025.108292_bib5","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1164\/rccm.201703-0449OC","article-title":"FULFIL trial: once-Daily triple therapy for patients with chronic obstructive pulmonary disease","volume":"196","author":"Lipson","year":"2017","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"10082","key":"10.1016\/j.rmed.2025.108292_bib6","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1016\/S0140-6736(17)30188-5","article-title":"Single inhaler extrafine triple therapy versus long-acting muscarinic antagonist therapy for chronic obstructive pulmonary disease (TRINITY): a double-blind, parallel group, randomised controlled trial","volume":"389","author":"Vestbo","year":"2017","journal-title":"Lancet"},{"issue":"10125","key":"10.1016\/j.rmed.2025.108292_bib7","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/S0140-6736(18)30206-X","article-title":"Extrafine inhaled triple therapy versus dual bronchodilator therapy in chronic obstructive pulmonary disease (TRIBUTE): a double-blind, parallel group, randomised controlled trial","volume":"391","author":"Papi","year":"2018","journal-title":"Lancet"},{"issue":"10048","key":"10.1016\/j.rmed.2025.108292_bib8","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/S0140-6736(16)31354-X","article-title":"Single inhaler triple therapy versus inhaled corticosteroid plus long-acting \u03b22-agonist therapy for chronic obstructive pulmonary disease (TRILOGY): a double-blind, parallel group, randomised controlled trial","volume":"388","author":"Singh","year":"2016","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.rmed.2025.108292_bib9","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1056\/NEJMoa1916046","article-title":"Triple inhaled therapy at two glucocorticoid doses in moderate-to-very-severe COPD","volume":"383","author":"Rabe","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"10","key":"10.1016\/j.rmed.2025.108292_bib10","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S2213-2600(18)30327-8","volume":"6","author":"Ferguson","year":"2018","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.rmed.2025.108292_bib11","series-title":"Multiple Criteria Decision Analysis: an Integrated Aapproach","author":"Belton","year":"2002"},{"issue":"1","key":"10.1016\/j.rmed.2025.108292_bib12","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jval.2016.08.724","article-title":"Evaluation of COPD treatments: a multicriteria decision analysis of aclidinium and tiotropium in the United States","volume":"20","author":"Marsh","year":"2017","journal-title":"Value Health"},{"issue":"2","key":"10.1016\/j.rmed.2025.108292_bib13","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1136\/thx.2007.082636","article-title":"Counting, analysing and reporting exacerbations of COPD in randomised controlled trials","volume":"63","author":"Aaron","year":"2008","journal-title":"Thorax"},{"key":"10.1016\/j.rmed.2025.108292_bib14","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jclinepi.2021.12.007","article-title":"Analyses of repeatedly measured continuous outcomes in randomized controlled trials needed substantial improvements","volume":"143","author":"Ren","year":"2022","journal-title":"J. Clin. Epidemiol."},{"issue":"2","key":"10.1016\/j.rmed.2025.108292_bib15","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jval.2015.12.016","article-title":"Multiple criteria decision analysis for health care decision making - emerging good practices: report 2 of the ISPOR MCDA emerging good practices task force","volume":"19","author":"Marsh","year":"2016","journal-title":"Value Health"},{"key":"10.1016\/j.rmed.2025.108292_bib16","article-title":"Triple therapy in the management of chronic obstructive pulmonary disease: systematic review and meta-analysis","volume":"363","author":"Zheng","year":"2018","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.rmed.2025.108292_bib17","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1186\/s12931-019-1213-9","article-title":"Single-inhaler triple therapy in patients with chronic obstructive pulmonary disease: a systematic review","volume":"20","author":"Langham","year":"2019","journal-title":"Respir. Res."},{"issue":"9","key":"10.1016\/j.rmed.2025.108292_bib18","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1164\/rccm.202003-0625ST","article-title":"Pharmacologic management of chronic obstructive pulmonary disease. An official American thoracic society clinical practice guideline","volume":"201","author":"Nici","year":"2020","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"12","key":"10.1016\/j.rmed.2025.108292_bib19","first-page":"CD011600","article-title":"Inhaled corticosteroids with combination inhaled long-acting beta2-agonists and long-acting muscarinic antagonists for chronic obstructive pulmonary disease","volume":"12","author":"van Geffen","year":"2023","journal-title":"Cochrane Database Syst. Rev."},{"issue":"1","key":"10.1016\/j.rmed.2025.108292_bib20","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1186\/s12931-021-01777-x","article-title":"Triple versus LAMA\/LABA combination therapy for patients with COPD: a systematic review and meta-analysis","volume":"22","author":"Koarai","year":"2021","journal-title":"Respir. Res."},{"issue":"15","key":"10.1016\/j.rmed.2025.108292_bib21","doi-asserted-by":"crossref","first-page":"4491","DOI":"10.3390\/jcm11154491","article-title":"Comparing the efficacy and safety profile of triple fixed-dose combinations in COPD: a meta-analysis and IBiS score","volume":"11","author":"Rogliani","year":"2022","journal-title":"J. Clin. Med."},{"issue":"2","key":"10.1016\/j.rmed.2025.108292_bib22","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1007\/s12325-024-03088-1","article-title":"Comparative effectiveness of fluticasone furoate\/umeclidinium\/vilanterol and budesonide\/glycopyrrolate\/formoterol fumarate among US patients with chronic obstructive pulmonary disease","volume":"42","author":"Mannino","year":"2025","journal-title":"Adv. Ther."},{"key":"10.1016\/j.rmed.2025.108292_bib23","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2024-080409","article-title":"Comparative effectiveness and safety of single inhaler triple therapies for chronic obstructive pulmonary disease: new user cohort study","volume":"387","author":"Feldman","year":"2024","journal-title":"BMJ"},{"issue":"5","key":"10.1016\/j.rmed.2025.108292_bib24","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1007\/s12325-024-02823-y","article-title":"Pharmacological basis of differences in dose response, dose equivalence, and duration of action of inhaled corticosteroids","volume":"41","author":"Daley-Yates","year":"2024","journal-title":"Adv. Ther."},{"issue":"10","key":"10.1016\/j.rmed.2025.108292_bib25","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1080\/17512433.2024.2408272","article-title":"Reducing the risk of death - a possible outcome in COPD patients","volume":"17","author":"Maniscalco","year":"2024","journal-title":"Expet Rev. Clin. Pharmacol."},{"issue":"10","key":"10.1016\/j.rmed.2025.108292_bib26","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1080\/03007995.2023.2247969","article-title":"Mortality risk reduction with budesonide\/glycopyrrolate\/formoterol fumarate versus fluticasone furoate\/umeclidinium\/vilanterol in COPD: a matching-adjusted indirect comparison based on ETHOS and IMPACT","volume":"39","author":"Stolz","year":"2023","journal-title":"Curr. Med. Res. Opin."},{"issue":"6","key":"10.1016\/j.rmed.2025.108292_bib27","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01230-2018","article-title":"Inhaled corticosteroid containing combinations and mortality in COPD","volume":"52","author":"Vestbo","year":"2018","journal-title":"Eur. Respir. J."},{"issue":"9","key":"10.1016\/j.rmed.2025.108292_bib28","doi-asserted-by":"crossref","first-page":"3957","DOI":"10.1007\/s12325-022-02231-0","article-title":"Fluticasone furoate\/umeclidinium\/vilanterol (FF\/UMEC\/VI) triple therapy compared with other therapies for the treatment of COPD: a network meta-analysis","volume":"39","author":"Ismaila","year":"2022","journal-title":"Adv. Ther."},{"issue":"6","key":"10.1016\/j.rmed.2025.108292_bib29","doi-asserted-by":"crossref","first-page":"3089","DOI":"10.1007\/s12325-021-01703-z","article-title":"Efficacy and safety of budesonide\/glycopyrronium\/formoterol fumarate versus other triple combinations in COPD: a systematic literature review and network meta-analysis","volume":"38","author":"Bourdin","year":"2021","journal-title":"Adv. Ther."},{"issue":"4","key":"10.1016\/j.rmed.2025.108292_bib30","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1164\/rccm.202303-0400SO","article-title":"An update on outcomes for COPD pharmacological trials: a COPD investigators report - reassessment of the 2008 American thoracic society\/european respiratory society statement on outcomes for COPD pharmacological trials","volume":"208","author":"Cazzola","year":"2023","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.rmed.2025.108292_bib31","first-page":"213","article-title":"Inhaled medication: which device for which patient?","volume":"69","author":"Cazzola","year":"2015","journal-title":"ERS Monogr"},{"issue":"4","key":"10.1016\/j.rmed.2025.108292_bib32","first-page":"488","article-title":"Pilot study of a patient experience with an ELLIPTA inhaler electronic medication monitor and associated integrated system: a prospective observational study using the COPD patient-powered research network","volume":"8","author":"Yawn","year":"2021","journal-title":"Chronic Obstr. Pulm Dis."},{"key":"10.1016\/j.rmed.2025.108292_bib33","doi-asserted-by":"crossref","first-page":"113","DOI":"10.2147\/COPD.S274846","article-title":"Consistent pulmonary drug delivery with whole lung deposition using the aerosphere inhaler: a review of the evidence","volume":"16","author":"Usmani","year":"2021","journal-title":"Int. J. Chronic Obstr. Pulm. Dis."},{"key":"10.1016\/j.rmed.2025.108292_bib34","doi-asserted-by":"crossref","first-page":"79","DOI":"10.2147\/COPD.S291030","article-title":"Comparison of dry-powder inhaler and pressurized metered-dose inhaler formulations of extrafine beclomethasone dipropionate\/formoterol fumarate\/glycopyrronium in patients with COPD: the TRI-D randomized controlled trial","volume":"16","author":"Beeh","year":"2021","journal-title":"Int. J. Chronic Obstr. Pulm. Dis."},{"key":"10.1016\/j.rmed.2025.108292_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2023.107439","article-title":"Is it preferable to administer a bronchodilator once- or twice-daily when treating COPD?","volume":"219","author":"Matera","year":"2023","journal-title":"Respir. Med."},{"key":"10.1016\/j.rmed.2025.108292_bib36","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.2147\/COPD.S511334","article-title":"Real-world effectiveness of triple extrafine fixed-dose combination with beclomethasone\/formoterol\/glycopyrronium on symptoms and lung function in COPD: a systematic review and meta-analysis","volume":"20","author":"Rogliani","year":"2025","journal-title":"Int. J. Chronic Obstr. Pulm. Dis."},{"issue":"5","key":"10.1016\/j.rmed.2025.108292_bib37","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.jval.2022.11.007","article-title":"The use of multicriteria decision analysis to support decision making in healthcare: an updated systematic kiterature review","volume":"26","author":"Gongora-Salazar","year":"2023","journal-title":"Value Health"},{"issue":"4","key":"10.1016\/j.rmed.2025.108292_bib38","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s40291-017-0266-z","article-title":"The challenges of precision medicine in COPD","volume":"21","author":"Cazzola","year":"2017","journal-title":"Mol. Diagn. Ther."},{"issue":"1","key":"10.1016\/j.rmed.2025.108292_bib39","first-page":"19","article-title":"Treatment preferences of patients with chronic obstructive pulmonary disease: results from qualitative interviews and focus groups in the United Kingdom, United States, and Germany","volume":"8","author":"Schroeder","year":"2021","journal-title":"Chronic Obstr Pulm Dis"},{"key":"10.1016\/j.rmed.2025.108292_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2022.106807","article-title":"Adherence and persistence to once-daily single-inhaler versus multiple-inhaler triple therapy among patients with chronic obstructive pulmonary disease in the USA: a real-world study","volume":"197","author":"Mannino","year":"2022","journal-title":"Respir. Med."},{"issue":"7","key":"10.1016\/j.rmed.2025.108292_bib41","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1016\/j.jaip.2023.03.053","article-title":"Is once versus twice daily dosing better for adherence in asthma and chronic obstructive pulmonary disease?","volume":"11","author":"De Keyser","year":"2023","journal-title":"J. Allergy Clin. Immunol. Pract."},{"issue":"6","key":"10.1016\/j.rmed.2025.108292_bib42","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1016\/j.jaip.2019.02.023","article-title":"ELLIPTA dry powder versus metered-dose inhalers in an optimized clinical trial setting","volume":"7","author":"Kerwin","year":"2019","journal-title":"J. Allergy Clin. Immunol. Pract."}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611125003555?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611125003555?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T15:54:09Z","timestamp":1767714849000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611125003555"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":41,"alternative-id":["S0954611125003555"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2025.108292","relation":{},"ISSN":["0954-6111"],"issn-type":[{"value":"0954-6111","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparing major COPD triple therapy trials using a structured multi-criteria decision analysis: A deep dive into patient populations and outcomes","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2025.108292","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"108292"}}